Cargando…
Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma
[Image: see text] Indoleamine 2,3-dioxygenase 1 (IDO1) is a potent immunosuppressive enzyme that inhibits the antitumor immune response through both tryptophan metabolism and non-enzymatic functions. To date, most IDO1-targeted approaches have focused on inhibiting tryptophan metabolism. However, th...
Autores principales: | Bollu, Lakshmi R., Bommi, Prashant V., Monsen, Paige J., Zhai, Lijie, Lauing, Kristen L., Bell, April, Kim, Miri, Ladomersky, Erik, Yang, Xinyu, Platanias, Leonidas C., Matei, Daniela E., Bonini, Marcelo G., Munshi, Hidayatullah G., Hashizume, Rintaro, Wu, Jennifer D., Zhang, Bin, James, Charles David, Chen, Peiwen, Kocherginsky, Masha, Horbinski, Craig, Cameron, Michael D., Grigorescu, Arabela A., Yamini, Bakhtiar, Lukas, Rimas V., Schiltz, Gary E., Wainwright, Derek A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743093/ https://www.ncbi.nlm.nih.gov/pubmed/36410047 http://dx.doi.org/10.1021/acs.jmedchem.2c00771 |
Ejemplares similares
-
Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancer
por: Rosenberg, Ari J., et al.
Publicado: (2018) -
Glioblastoma as an age-related neurological disorder in adults
por: Kim, Miri, et al.
Publicado: (2021) -
The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With Glioblastoma
por: Ladomersky, Erik, et al.
Publicado: (2019) -
The kynurenine pathway implicated in patient delirium: possible indications for indoleamine 2,3 dioxygenase inhibitors
por: Heimberger, Amy B., et al.
Publicado: (2023) -
Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma
por: Zhai, Lijie, et al.
Publicado: (2021)